ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jarecki-Black, J.
Right arrow Articles by Glassman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jarecki-Black, J.
Right arrow Articles by Glassman, A.
Annals of Clinical and Laboratory Science, Vol 16, Issue 6, 450-454
Copyright © 1986 by Association of Clinical Scientists


Articles

Effect of hydroxyethyl starch (HES) in reducing parasite load in experimental visceral leishmaniasis

JC Jarecki-Black, L Atkins, KM Pratt, SH Pepkowitz, and AB Glassman

Leishmania donovani primarily infects phagocytic cells of the reticuloendothelial system. Hydroxyethyl starch (HES) has been shown to concentrate transiently in these organs. The effect of HES administration was assessed upon infection and also upon vaccination against this parasite. Animals received HES intraperitoneally thrice weekly, either alone (HES) or with a subcutaneous immunization protocol utilizing aluminum hydroxide and killed parasites (ALP-HES). Controls were untreated (NT) or received only the vaccination protocol (ALP). Results showed that animals treated with HES alone exhibited significantly fewer parasites as compared to untreated animals (p less than 0.001). The ALP animals also were protected against infection but demonstrated greater parasite burdens than HES animals. Immunized animals which also received HES demonstrated infection levels similar to those treated with HES alone, thus negating any synergistic effect. The reason for increased protection against L. donovani infection in animals treated with HES is not clear, but it may result from a transient increase in host resistance.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the Association of Clinical Scientists.